Christian B. Dinneen-Long
General Counsel at GLYCOMIMETICS, INC.
Profile
Christian B.
Dinneen-Long is currently the Secretary, Vice President & Corporate Counsel at GlycoMimetics, Inc. He previously worked as an Assistant General Counsel at Guilford Pharmaceuticals, Inc., an Associate General Counsel at Emergent BioSolutions, Inc., and a Senior Counsel at Medimmune, Inc. He received his undergraduate degree from the University of Wisconsin and his graduate degree from Chicago-Kent College of Law.
Christian B. Dinneen-Long active positions
| Companies | Position | Start |
|---|---|---|
| GLYCOMIMETICS, INC. | General Counsel | 29/04/2019 |
Former positions of Christian B. Dinneen-Long
| Companies | Position | End |
|---|---|---|
| EMERGENT BIOSOLUTIONS INC. | General Counsel | - |
Guilford Pharmaceuticals, Inc.
 Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | General Counsel | - |
| Medimmune, Inc. | General Counsel | - |
Training of Christian B. Dinneen-Long
| University of Wisconsin | Undergraduate Degree |
| Chicago-Kent College of Law | Graduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| GLYCOMIMETICS, INC. | Health Technology |
| EMERGENT BIOSOLUTIONS INC. | Health Technology |
| Private companies | 2 |
|---|---|
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Health Technology |
| Medimmune, Inc. | Health Technology |
- Stock Market
- Insiders
- Christian B. Dinneen-Long
